Longer Lytic-PCI Window; Virtual Heart Teams; Large Vessel Occlusion Blood Test?

For some heart attack patients in resource-limited settings, allowing a longer window from fibrinolysis to percutaneous coronary intervention (PCI) may not necessarily hurt outcomes, observational data suggested. (American Journal of Cardiology)

Care efficiency for complex coronary artery disease was improved with real-time, online heart team discussions during angiography, a randomized trial showed. (Journal of the American College of Cardiology)

Artificial intelligence screening tools were trained to comb through electronic health records to identify people at risk of sudden cardiac death and those with undiagnosed atrial fibrillation. (European Journal of Preventive Cardiology)

Philips said it got FDA 510(k) clearance for SmartHeart, an artificial intelligence-powered cardiac MRI planning tool that can reduce the number of patient breath holds during imaging.

A wide spectrum of primary aldosteronism can be linked to incident atrial fibrillation, incident ischemic stroke, and combined incident cardiovascular disease and all-cause mortality regardless of hypertension status, according to a cohort study. (JAMA Cardiology)

Point-of-care blood tests were able to differentiate large vessel occlusion from intracerebral hemorrhage in suspected stroke patients, a retrospective study suggested. (Stroke: Vascular and Interventional Neurology)

Researchers said that hemorrhagic transformation after recanalization therapy, linked to worse functional recovery after a stroke, can be predicted by noncontrast CT-derived biomarkers. (Stroke)

Exercise echocardiography may be needed to better evaluate patients after transcatheter aortic valve replacement, as some patients had higher gradients during exercise despite normal resting echo findings in an exploratory pilot study. (JSCAI)

The Relief system, comprising an integrated valve-and-sensor implant positioned in the inferior vena cava, showed promise for aiding decongestion in heart failure while supporting renal function, Relief Cardiovascular announced.

The sarcomere gene variant type of hypertrophic cardiomyopathy was associated with worse prognosis, and patients may benefit from more vigilant surveillance for arrhythmias and systolic dysfunction, a longitudinal cohort study showed. (Circulation)

Preclinical work supported gene therapy that preserves telomeres to protect the heart in heart failure. (eBioMedicine)

In the STRIDE trial, semaglutide (Ozempic, Wegovy) consistently improved walking capacity in patients with peripheral artery disease across age and disease severity. (European Heart Journal)

It was likely that cardiac troponin elevations in hospitalized COVID-19 patients had something to do with systemic vascular injury, a proteomic analysis found. (Heart)